Table 1
From: Clinical effect of interleukin-2 (IL-2) immuno-adjuvant treatment in HIV+ advanced naïve patients
Group | Median CD4/μL change from BL (T3 mths) | Median CD4/μL change from BL (T6 mths) | Median CD4/μL change from BL (T18 mths) |
|---|---|---|---|
IL-2+HAART patients (n = 33) | +145 | +59 | +107 |
IL-2R (n = 23/33) | +161 | +91 | +135 |
IL-2 NR (n = 10/33) | +95 | +28 | +74 |
HAART controls (n = 40) | +20 | +59 | +97 |